Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers


  Free Subscription


4 Am J Med
8 Ann Intern Med
3 Antimicrob Agents Chemother
1 Antiviral Res
1 Biochemistry (Mosc)
23 BMJ
4 Cell
4 Drug Saf
7 Epidemiol Infect
5 Eur J Epidemiol
2 J Clin Microbiol
2 J Exp Med
1 J Immunol
10 J Infect Dis
4 J Virol
1 J Virol Methods
17 Lancet
16 MMWR Morb Mortal Wkly Rep
23 N Engl J Med
9 Pediatrics
2 PLoS Biol
5 PLoS Comput Biol
68 PLoS One
20 Proc Natl Acad Sci U S A
6 Vaccine
2 Virology
9 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. WU JH, John SD, Adashi EY
    Allocating Vaccines in a Pandemic: The Ethical Dimension.
    Am J Med. 2020;133:1241-1242.

  2. FINS JJ, Miller FG
    Proportionality, Pandemics, and Medical Ethics.
    Am J Med. 2020;133:1243-1244.

  3. MORAN P
    Social Media: A Pandemic of Misinformation.
    Am J Med. 2020;133:1247-1248.

  4. KAUFMAN AC, Brewster R, Rajasekaran K
    How to Perform a Nasopharyngeal Swab - An Otolaryngology Perspective.
    Am J Med. 2020;133:1280-1282.

    Ann Intern Med

  5. BEACH MC, Lederman HM, Singleton M, Brower RG, et al
    Desperate Times: Protecting the Public From Research Without Consent or Oversight During Public Health Emergencies.
    Ann Intern Med. 2020;173:926-928.

    Seven O'Clock.
    Ann Intern Med. 2020;173:313-314.

    Facing Death in a Pandemic.
    Ann Intern Med. 2020;173:401.

  8. FRYHOFER SA, Fryhofer GW
    Vaccination-Induced Bursitis: Technique Matters.
    Ann Intern Med. 2020 Jun 23. doi: 10.7326/M20-3302.

  9. SEARS D, Ahalt C, Augustine D, Williams B, et al
    Occupational Health: A Key to the Control of COVID-19 in Correctional Facilities.
    Ann Intern Med. 2020 Jul 27. doi: 10.7326/M20-4543.

  10. LUO L, Liu D, Liao X, Wu X, et al
    Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China: A Prospective Cohort Study.
    Ann Intern Med. 2020 Aug 13. doi: 10.7326/M20-2671.
    PubMed         Abstract available

  11. THOMAS R, Lotfi T, Morgano GP, Darzi A, et al
    Update Alert 2: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
    Ann Intern Med. 2020 Oct 13. doi: 10.7326/L20-1211.

  12. HERNANDEZ AV, Roman YM, Pasupuleti V, Barboza JJ, et al
    Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/L20-1257.

    Antimicrob Agents Chemother

  13. YAN VC, Muller FL
    Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity.
    Antimicrob Agents Chemother. 2020;64.

  14. LE MP, Le Beller C, Le Hingrat Q, Jaquet P, et al
    Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity".
    Antimicrob Agents Chemother. 2020;64.

  15. DOI Y, Hibino M, Hase R, Yamamoto M, et al
    A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
    Antimicrob Agents Chemother. 2020;64.
    PubMed         Abstract available

    Antiviral Res

  16. CHOI SW, Shin JS, Park SJ, Jung E, et al
    Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
    Antiviral Res. 2020 Oct 19:104955. doi: 10.1016/j.antiviral.2020.104955.
    PubMed         Abstract available

    Biochemistry (Mosc)

  17. VOROBJEVA NV, Chernyak BV
    NETosis: Molecular Mechanisms, Role in Physiology and Pathology.
    Biochemistry (Mosc). 2020;85:1178-1190.
    PubMed         Abstract available


  18. GREEN ST, Cladi L
    Covid-19: Should the UK mandate more stringent workplace protection for older people?
    BMJ. 2020;371:m4528.

  19. Update to living WHO guideline on drugs for covid-19.
    BMJ. 2020;371:m4475.

  20. DALTON AE, Christensen TL, Starling HF
    Effect of video conference clinics on medical education.
    BMJ. 2020;371:m4492.

  21. ATAULLAHJAN A, Samara M, Betancourt TS, Bhutta ZA, et al
    Mitigating toxic stress in children affected by conflict and displacement.
    BMJ. 2020;371:m2876.

  22. MEHMI AK, Winters D, Green JSA
    Video consultations will increase health inequality without the correct infrastructure put in place.
    BMJ. 2020;371:m4498.

    NHS reorganisation after the pandemic.
    BMJ. 2020;371:m4468.

  24. GILL M, Gray M
    Mass testing for covid-19 in the UK.
    BMJ. 2020;371:m4436.

  25. JENSEN L
    "Just stay at home" was lonely and terrifying.
    BMJ. 2020;371:m3807.

    Clinically extremely vulnerable adults should not leave home for work, says new advice.
    BMJ. 2020;371:m4292.

  27. KHUNTI K, Routen A, Pareek M, Treweek S, et al
    The language of ethnicity.
    BMJ. 2020;371:m4493.

  28. ARSHAD M, Mahmood SF, Khan M, Hasan R, et al
    Covid -19, misinformation, and antimicrobial resistance.
    BMJ. 2020;371:m4501.

  29. EYTHORSSON E, Helgason D, Ingvarsson RF, Bjornsson HK, et al
    Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study.
    BMJ. 2020;371:m4529.
    PubMed         Abstract available

  30. LOKUGAMAGE AU, Bowen MA, Blair J
    Long covid: doctors must assess and investigate patients properly.
    BMJ. 2020;371:m4583.

  31. MARK HE, Dias da Costa G, Pagliari C, Unger SA, et al
    Malnutrition: the silent pandemic.
    BMJ. 2020;371:m4593.

  32. FONSEKA TR, Ellis RJ
    The personal impact of covid-19 on trainees.
    BMJ. 2020;371:m4688.

  33. PATEL V, Rizki H, Varghese J
    A mindful response to doctors' mental health.
    BMJ. 2020;371:m4687.

  34. ZACHARIAS J, Joffe M
    Pandemic communications: follow the science but lead with psychology.
    BMJ. 2020;371:m4647.

  35. MAJEED A, Molokhia M
    Vaccinating the UK against covid-19.
    BMJ. 2020;371:m4654.

  36. PASTOR-BARRIUSO R, Perez-Gomez B, Hernan MA, Perez-Olmeda M, et al
    Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
    BMJ. 2020;371:m4509.
    PubMed         Abstract available

  37. SCHWARTZ IS, Heil EL, McCreary EK
    Remdesivir: a pendulum in a pandemic.
    BMJ. 2020;371:m4560.

  38. DUNCAN H
    Covid-19 vaccine: we are sleepwalking into a massive prospective cohort study.
    BMJ. 2020;371:m4568.

  39. COX C, Dixon-Woods M
    Need for ethical framework to guide mass testing for asymptomatic covid-19.
    BMJ. 2020;371:m4567.

  40. XIE Y, Bowe B, Maddukuri G, Al-Aly Z, et al
    Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study.
    BMJ. 2020;371:m4677.


  41. AID M, Busman-Sahay K, Vidal SJ, Maliga Z, et al
    Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Cell. 2020;183:1354-1366.
    PubMed         Abstract available

  42. BANERJEE AK, Blanco MR, Bruce EA, Honson DD, et al
    SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Cell. 2020;183:1325-1339.
    PubMed         Abstract available

  43. MECKIFF BJ, Ramirez-Suastegui C, Fajardo V, Chee SJ, et al
    Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
    Cell. 2020;183:1340-1353.
    PubMed         Abstract available

  44. WALLS AC, Fiala B, Schafer A, Wrenn S, et al
    Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
    Cell. 2020;183:1367-1382.
    PubMed         Abstract available

    Drug Saf

  45. GARCIA P, Revet A, Yrondi A, Rousseau V, et al
    Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
    Drug Saf. 2020;43:1315-1322.
    PubMed         Abstract available

    Assessing the Safety of COVID-19 Vaccines: A Primer.
    Drug Saf. 2020;43:1205-1210.
    PubMed         Abstract available

  47. ZEKARIAS A, Watson S, Vidlin SH, Grundmark B, et al
    Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
    Drug Saf. 2020;43:1309-1314.
    PubMed         Abstract available

  48. TRIFIRO G, Massari M, Da Cas R, Menniti Ippolito F, et al
    Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Drug Saf. 2020;43:1297-1308.
    PubMed         Abstract available

    Epidemiol Infect

  49. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    PubMed         Abstract available

  50. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    PubMed         Abstract available

  51. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    PubMed         Abstract available

  52. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    PubMed         Abstract available

  53. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    PubMed         Abstract available

  54. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    PubMed         Abstract available

  55. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    PubMed         Abstract available

    Eur J Epidemiol

  56. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    PubMed         Abstract available

  57. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    PubMed         Abstract available

  58. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    PubMed         Abstract available

  59. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    PubMed         Abstract available

  60. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.

    J Clin Microbiol

  61. LUCHSINGER LL, Ransegnola BP, Jin DK, Muecksch F, et al
    Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  62. MITCHELL SL, Ventura SE
    Evaluation and Comparison of the Hologic Aptima SARS-CoV-2 Assay and the CDC 2019-nCoV Real-Time Reverse Transcription-PCR Diagnostic Panel Using a Four-Sample Pooling Approach.
    J Clin Microbiol. 2020;58.

    J Exp Med

  63. RODRIGUES TS, de Sa KSG, Ishimoto AY, Becerra A, et al
    Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    J Exp Med. 2021;218.
    PubMed         Abstract available

  64. LU Y, Jiang R, Freyn AW, Wang J, et al
    CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Immunol

  65. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    PubMed         Abstract available

    J Infect Dis

  66. ZOU Y, Wang BR, Sun L, Xu S, et al
    The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
    J Infect Dis. 2020;222:1784-1788.
    PubMed         Abstract available

  67. GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
    Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
    J Infect Dis. 2020;222:1789-1793.
    PubMed         Abstract available

  68. STERLING RK, Oakes T, Gal TS, Stevens MP, et al
    The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1794-1797.
    PubMed         Abstract available

  69. TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
    Are SARS-CoV-2 seroprevalence estimates biased?
    J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.

  70. NALIN D
    Immunosenescence and SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.

  71. KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
    Influenza Vaccine Failure Associated with Age and Immunosuppression.
    J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
    PubMed         Abstract available

  72. FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
    Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
    PubMed         Abstract available

  73. FALASCA L, Nardacci R, Colombo D, Lalle E, et al
    Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
    J Infect Dis. 2020;222:1807-1815.
    PubMed         Abstract available

  74. ZIMMERMAN RK, South-Paul JE, Poland GA
    Rationing of civilian COVID-19 vaccines while supplies are limited.
    J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.

  75. BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
    Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1798-1806.
    PubMed         Abstract available

    J Virol

  76. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    PubMed         Abstract available

  77. KINDER JT, Moncman CL, Barrett C, Jin H, et al
    Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    J Virol. 2020;94.
    PubMed         Abstract available

  78. DENG Y, Herbert JA, Robinson E, Ren L, et al
    Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    J Virol. 2020;94.
    PubMed         Abstract available

  79. GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
    Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
    J Virol. 2020;94.
    PubMed         Abstract available

    J Virol Methods

  80. KODE SS, Pawar SD, Tare DS, Mullick J, et al
    Application of frozen and stored glutaraldehyde-fixed Turkey red blood cells for hemagglutination and hemagglutination inhibition assays for the detection and identification of influenza viruses.
    J Virol Methods. 2020 Dec 14:114046. doi: 10.1016/j.jviromet.2020.114046.
    PubMed         Abstract available


  81. BILINSKI A, Emanuel EJ
    COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries.
    JAMA. 2020 Oct 12. pii: 2771841. doi: 10.1001/jama.2020.20717.

  82. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.

  83. OMER SB, Yildirim I, Forman HP
    Herd Immunity and Implications for SARS-CoV-2 Control.
    JAMA. 2020 Oct 19. pii: 2772167. doi: 10.1001/jama.2020.20892.

  84. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.

  85. SAAG MS
    Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science.
    JAMA. 2020 Nov 9. pii: 2772921. doi: 10.1001/jama.2020.22389.

  86. SELF WH, Semler MW, Leither LM, Casey JD, et al
    Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Nov 9. pii: 2772922. doi: 10.1001/jama.2020.22240.
    PubMed         Abstract available

    Reflections of a COVID-19 Long Hauler.
    JAMA. 2020 Nov 11. pii: 2773056. doi: 10.1001/jama.2020.22130.

  88. KIM PS, Read SW, Fauci AS
    Therapy for Early COVID-19: A Critical Need.
    JAMA. 2020 Nov 11. pii: 2773058. doi: 10.1001/jama.2020.22813.

    Four COVID-19 Lessons for Achieving Health Equity.
    JAMA. 2020;324:2245-2246.

  90. ABBASI J
    Using Smartwatch Data to Detect COVID-19 Cases Early.
    JAMA. 2020;324:2247.

  91. VAHIA IV, Jeste DV, Reynolds CF 3rd
    Older Adults and the Mental Health Effects of COVID-19.
    JAMA. 2020 Nov 20. pii: 2773479. doi: 10.1001/jama.2020.21753.

  92. DATTA SD, Talwar A, Lee JT
    A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications.
    JAMA. 2020 Nov 18. pii: 2773338. doi: 10.1001/jama.2020.22717.

  93. WANG EA, Western B, Berwick DM
    COVID-19, Decarceration, and the Role of Clinicians, Health Systems, and Payers: A Report From the National Academy of Sciences, Engineering, and Medicine.
    JAMA. 2020 Nov 16. pii: 2773226. doi: 10.1001/jama.2020.22109.

  94. SEYMOUR CW, Bauchner H, Golub RM
    COVID-19 Infection-Preventing Clinical Deterioration.
    JAMA. 2020 Nov 12. pii: 2773107. doi: 10.1001/jama.2020.21720.

  95. LENZE EJ, Mattar C, Zorumski CF, Stevens A, et al
    Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
    JAMA. 2020 Nov 12. pii: 2773108. doi: 10.1001/jama.2020.22760.
    PubMed         Abstract available

  96. ABBASI J
    Younger Adults Caught in COVID-19 Crosshairs as Demographics Shift.
    JAMA. 2020 Nov 11. pii: 2773055. doi: 10.1001/jama.2020.21913.


    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.

  98. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.

  99. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.

  100. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.

  101. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.

  102. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.

  103. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.

  104. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.

  105. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.

  106. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.

  107. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.

  108. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.

  109. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.

  110. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.

    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.

  112. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.

    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.

    MMWR Morb Mortal Wkly Rep

  114. PODEWILS LJ, Burket TL, Mettenbrink C, Steiner A, et al
    Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino - Denver, Colorado March-October 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1812-1816.
    PubMed         Abstract available

  115. PEREZ S, Innes GK, Walters MS, Mehr J, et al
    Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1827-1831.
    PubMed         Abstract available

  116. CENTER KE, Da Silva J, Hernandez AL, Vang K, et al
    Multidisciplinary Community-Based Investigation of a COVID-19 Outbreak Among Marshallese and Hispanic/Latino Communities - Benton and Washington Counties, Arkansas, March-June 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1807-1811.
    PubMed         Abstract available

  117. COVID-19 Stats: COVID-19 Incidence,* by Urban-Rural Classification(dagger) - United States, January 22-October 31, 2020( section sign).
    MMWR Morb Mortal Wkly Rep. 2020;69:1753.

  118. JENKINS R, Burke RM, Hamilton J, Fazekas K, et al
    Notes from the Field: Development of an Enhanced Community-Focused COVID-19 Surveillance Program - Hopi Tribe, JuneJuly 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1660-1661.

  119. CORONADO F, Blough S, Bergeron D, Proia K, et al
    Implementing Mitigation Strategies in Early Care and Education Settings for Prevention of SARS-CoV-2 Transmission - Eight States, September-October 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1868-1872.
    PubMed         Abstract available

  120. ARRAZOLA J, Masiello MM, Joshi S, Dominguez AE, et al
    COVID-19 Mortality Among American Indian and Alaska Native Persons - 14 States, January-June 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1853-1856.
    PubMed         Abstract available

  121. HONEIN MA, Christie A, Rose DA, Brooks JT, et al
    Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1860-1867.
    PubMed         Abstract available

  122. ROMERO L, Pao LZ, Clark H, Riley C, et al
    Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1895-1901.
    PubMed         Abstract available

  123. HOBBS CV, Martin LM, Kim SS, Kirmse BM, et al
    Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years - Mississippi, September-November 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1925-1929.
    PubMed         Abstract available

  124. DEMEKE HB, Pao LZ, Clark H, Romero L, et al
    Telehealth Practice Among Health Centers During the COVID-19 Pandemic - United States, July 11-17, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1902-1905.
    PubMed         Abstract available

  125. RICE KL, Miller GF, Coronado F, Meltzer MI, et al
    Estimated Resource Costs for Implementation of CDC's Recommended COVID-19 Mitigation Strategies in Pre-Kindergarten through Grade 12 Public Schools - United States, 2020-21 School Year.
    MMWR Morb Mortal Wkly Rep. 2020;69:1917-1921.
    PubMed         Abstract available

  126. OLIVER SE, Gargano JW, Marin M, Wallace M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1922-1924.
    PubMed         Abstract available

  127. RUBENSTEIN BL, Campbell S, Meyers AR, Crum DA, et al
    Factors That Might Affect SARS-CoV-2 Transmission Among Foreign-Born and U.S.-Born Poultry Facility Workers - Maryland, May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1906-1910.
    PubMed         Abstract available

  128. GILBERT LK, Strine TW, Szucs LE, Crawford TN, et al
    Racial and Ethnic Differences in Parental Attitudes and Concerns About School Reopening During the COVID-19 Pandemic - United States, July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1848-1852.
    PubMed         Abstract available

  129. SWEDO E, Idaikkadar N, Leemis R, Dias T, et al
    Trends in U.S. Emergency Department Visits Related to Suspected or Confirmed Child Abuse and Neglect Among Children and Adolescents Aged <18 Years Before and During the COVID-19 Pandemic - United States, January 2019-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1841-1847.
    PubMed         Abstract available

    N Engl J Med

  130. STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
    Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
    PubMed         Abstract available

  131. RAFIEI Y, Mello MM
    The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.

  132. KRAUSE PR, Gruber MF
    Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.

  133. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.

  134. RASMUSSEN SA, Lyerly AD, Jamieson DJ
    Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.

  135. MINA MJ, Parker R, Larremore DB
    Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631.

  136. EVANS ML, Lindauer M, Farrell ME
    A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19.
    N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046.

  137. BLOOM BR, Nowak GJ, Orenstein W
    "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.

  138. KEECH C, Albert G, Cho I, Robertson A, et al
    Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
    N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
    PubMed         Abstract available

  139. HALABI S, Heinrich A, Omer SB
    No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.

  140. COWIE BC, MacLachlan JH
    Early Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020;383.

  141. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Caring for Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:e140.

  142. HUANG E, Jordan SC
    Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
    N Engl J Med. 2020;383:2387-2388.

  143. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
    N Engl J Med. 2020;383:e143.

    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.

  145. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Studies of Covid-19 Transmission.
    N Engl J Med. 2020;383:e138.

  146. LAHEY T
    The Bottom of the Health Care Rationing Iceberg.
    N Engl J Med. 2020;383:2200-2201.

  147. MANZANO GS, Woods JK, Amato AA
    Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
    N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.

  148. MATIAS WR, Vaidya A, Brigl M, Bebell LM, et al
    A Patient with Fever and Dyspnea.
    N Engl J Med. 2020;383:e111.

  149. MALINA S, Warbelow S, Radix AE
    Two Steps Back - Rescinding Transgender Health Protections in Risky Times.
    N Engl J Med. 2020;383:e116.

  150. XING Y, Wong GWK, Ni W, Hu X, et al
    Rapid Response to an Outbreak in Qingdao, China.
    N Engl J Med. 2020;383:e129.

  151. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.

  152. GUDBJARTSSON DF, Stefansson K
    Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
    N Engl J Med. 2020;383.


  153. SISK B, Cull W, Harris JM, Rothenburger A, et al
    National Trends of Cases of COVID-19 in Children Based on US State Health Department Data.
    Pediatrics. 2020;146.

  154. LUGLI L, Bedetti L, Lucaccioni L, Gennari W, et al
    An Uninfected Preterm Newborn Inadvertently Fed SARS-CoV-2-Positive Breast Milk.
    Pediatrics. 2020 Aug 25. pii: peds.2020-004960. doi: 10.1542/peds.2020-004960.

  155. ROSTAD CA, Chahroudi A, Mantus G, Lapp SA, et al
    Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Pediatrics. 2020;146.
    PubMed         Abstract available

  156. PANG J, Boshier FAT, Alders N, Dixon G, et al
    SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.
    Pediatrics. 2020;146.

  157. PARRI N, Lenge M, Cantoni B, Arrighini A, et al
    COVID-19 in 17 Italian Pediatric Emergency Departments.
    Pediatrics. 2020;146.
    PubMed         Abstract available

  158. CRUZ AT, Shaman J, Dayan PS
    The Challenge of Clearly Counting COVID-19 Cases in Children.
    Pediatrics. 2020;146.

  159. WILDER JL, Parsons CR, Growdon AS, Toomey SL, et al
    Pediatric Hospitalizations During the COVID-19 Pandemic.
    Pediatrics. 2020;146.

  160. CHOI NH, Fremed M, Starc T, Weller R, et al
    MIS-C and Cardiac Conduction Abnormalities.
    Pediatrics. 2020;146.
    PubMed         Abstract available

  161. ZEICHNER SL, Cruz AT
    Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology.
    Pediatrics. 2020;146.

    PLoS Biol

  162. ALTHOUSE BM, Wenger EA, Miller JC, Scarpino SV, et al
    Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control.
    PLoS Biol. 2020;18:e3000897.
    PubMed         Abstract available

  163. ZHOU Y, Hou Y, Shen J, Mehra R, et al
    A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    PLoS Biol. 2020;18:e3000970.
    PubMed         Abstract available

    PLoS Comput Biol

  164. CATALA M, Alonso S, Alvarez-Lacalle E, Lopez D, et al
    Empirical model for short-time prediction of COVID-19 spreading.
    PLoS Comput Biol. 2020;16:e1008431.
    PubMed         Abstract available

  165. GOSTIC KM, McGough L, Baskerville EB, Abbott S, et al
    Practical considerations for measuring the effective reproductive number, Rt.
    PLoS Comput Biol. 2020;16:e1008409.
    PubMed         Abstract available

  166. RODRIGUES JPGLM, Barrera-Vilarmau S, M C Teixeira J, Sorokina M, et al
    Insights on cross-species transmission of SARS-CoV-2 from structural modeling.
    PLoS Comput Biol. 2020;16:e1008449.
    PubMed         Abstract available

  167. ANDERSON SC, Edwards AM, Yerlanov M, Mulberry N, et al
    Quantifying the impact of COVID-19 control measures using a Bayesian model of physical distancing.
    PLoS Comput Biol. 2020;16:e1008274.
    PubMed         Abstract available

  168. RILLIG MC, Bielcik M, Chaudhary VB, Grunfeld L, et al
    Ten simple rules for increased lab resilience.
    PLoS Comput Biol. 2020;16:e1008313.
    PubMed         Abstract available

    PLoS One

  169. BONFANTI N, Gundert E, Drewry AM, Goff K, et al
    Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study.
    PLoS One. 2020;15:e0243190.
    PubMed         Abstract available

  170. GEL ES, Jehn M, Lant T, Muldoon AR, et al
    COVID-19 healthcare demand projections: Arizona.
    PLoS One. 2020;15:e0242588.
    PubMed         Abstract available

  171. MORAES RR, Correa MB, Queiroz AB, Daneris A, et al
    COVID-19 challenges to dentistry in the new pandemic epicenter: Brazil.
    PLoS One. 2020;15:e0242251.
    PubMed         Abstract available

  172. LI N, Kong H, Zheng XZ, Li XY, et al
    Early predictive factors of progression from severe type to critical ill type in patients with Coronavirus Disease 2019: A retrospective cohort study.
    PLoS One. 2020;15:e0243195.
    PubMed         Abstract available

  173. WU YY, Wang SH, Wu CH, Yen LC, et al
    In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naive B cells as a trigger for severe immune responses in the lungs of COVID-19 patients.
    PLoS One. 2020;15:e0242900.
    PubMed         Abstract available

  174. JEONG SJ, Chung WS, Sohn Y, Hyun JH, et al
    Clinical characteristics and online mental health care of asymptomatic or mildly symptomatic patients with coronavirus disease 2019.
    PLoS One. 2020;15:e0242130.
    PubMed         Abstract available

  175. CHEN CP, Lin YC, Chen TC, Tseng TY, et al
    A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
    PLoS One. 2020;15:e0242763.
    PubMed         Abstract available

  176. BARCELO J, Sheen GC
    Voluntary adoption of social welfare-enhancing behavior: Mask-wearing in Spain during the COVID-19 outbreak.
    PLoS One. 2020;15:e0242764.
    PubMed         Abstract available

  177. JOHN-HENDERSON NA, Mueller CM
    The relationship between health mindsets and health protective behaviors: An exploratory investigation in a convenience sample of American Indian adults during the COVID-19 pandemic.
    PLoS One. 2020;15:e0242902.
    PubMed         Abstract available

  178. MOTA NB, Weissheimer J, Ribeiro M, de Paiva M, et al
    Dreaming during the Covid-19 pandemic: Computational assessment of dream reports reveals mental suffering related to fear of contagion.
    PLoS One. 2020;15:e0242903.
    PubMed         Abstract available

  179. YERKES MA, Andre SCH, Besamusca JW, Kruyen PM, et al
    'Intelligent' lockdown, intelligent effects? Results from a survey on gender (in)equality in paid work, the division of childcare and household work, and quality of life among parents in the Netherlands during the Covid-19 lockdown.
    PLoS One. 2020;15:e0242249.
    PubMed         Abstract available

  180. KEBEDE Y, Birhanu Z, Fufa D, Yitayih Y, et al
    Myths, beliefs, and perceptions about COVID-19 in Ethiopia: A need to address information gaps and enable combating efforts.
    PLoS One. 2020;15:e0243024.
    PubMed         Abstract available

  181. ALI M, Khan DM, Aamir M, Khalil U, et al
    Forecasting COVID-19 in Pakistan.
    PLoS One. 2020;15:e0242762.
    PubMed         Abstract available

  182. ASSELMANN E, Borghans L, Montizaan R, Seegers P, et al
    The role of personality in the thoughts, feelings, and behaviors of students in Germany during the first weeks of the COVID-19 pandemic.
    PLoS One. 2020;15:e0242904.
    PubMed         Abstract available

  183. ZHANG B, Zhou H, Zhou F
    Study on SARS-CoV-2 transmission and the effects of control measures in China.
    PLoS One. 2020;15:e0242649.
    PubMed         Abstract available

  184. YANG L, Jin J, Luo W, Gan Y, et al
    Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243124.
    PubMed         Abstract available

  185. DAR SA, Khurshid SQ, Wani ZA, Khanam A, et al
    Stigma in coronavirus disease-19 survivors in Kashmir, India: A cross-sectional exploratory study.
    PLoS One. 2020;15:e0240152.
    PubMed         Abstract available

  186. ALSOUFI A, Alsuyihili A, Msherghi A, Elhadi A, et al
    Impact of the COVID-19 pandemic on medical education: Medical students' knowledge, attitudes, and practices regarding electronic learning.
    PLoS One. 2020;15:e0242905.
    PubMed         Abstract available

  187. LODA T, Loffler T, Erschens R, Zipfel S, et al
    Medical education in times of COVID-19: German students' expectations - A cross-sectional study.
    PLoS One. 2020;15:e0241660.
    PubMed         Abstract available

  188. MUNOZ-MORENO R, Chaves-Montero A, Morilla-Luchena A, Vazquez-Aguado O, et al
    COVID-19 and social services in Spain.
    PLoS One. 2020;15:e0241538.
    PubMed         Abstract available

  189. CHIDAMBARAM V, Tun NL, Haque WZ, Majella MG, et al
    Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241541.
    PubMed         Abstract available

  190. Early indicators of intensive care unit bed requirement during the COVID-19 epidemic: A retrospective study in Ile-de-France region, France.
    PLoS One. 2020;15:e0241406.
    PubMed         Abstract available

  191. SACCO V, Rauch B, Gar C, Haschka S, et al
    Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19.
    PLoS One. 2020;15:e0237799.
    PubMed         Abstract available

  192. LOU E, Teoh D, Brown K, Blaes A, et al
    Perspectives of cancer patients and their health during the COVID-19 pandemic.
    PLoS One. 2020;15:e0241741.
    PubMed         Abstract available

  193. CYPRYANSKA M, Nezlek JB
    Anxiety as a mediator of relationships between perceptions of the threat of COVID-19 and coping behaviors during the onset of the pandemic in Poland.
    PLoS One. 2020;15:e0241464.
    PubMed         Abstract available

  194. ALSHAMI A, Alattas R, Anan H, Alhalimi A, et al
    Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia.
    PLoS One. 2020;15:e0241258.
    PubMed         Abstract available

  195. MAKSIMOWSKI N, Williams VR, Scholey JW
    Kidney ACE2 expression: Implications for chronic kidney disease.
    PLoS One. 2020;15:e0241534.
    PubMed         Abstract available

  196. DEVIAENE M, Weigel KM, Wood RC, Luabeya AKK, et al
    Sample adequacy controls for infectious disease diagnosis by oral swabbing.
    PLoS One. 2020;15:e0241542.
    PubMed         Abstract available

  197. WANG Y, Xu G, Huang YW
    Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speaking.
    PLoS One. 2020;15:e0241539.
    PubMed         Abstract available

  198. FU YQ, Sun YL, Lu SW, Yang Y, et al
    Effect of blood analysis and immune function on the prognosis of patients with COVID-19.
    PLoS One. 2020;15:e0240751.
    PubMed         Abstract available

  199. RUSSO L, Anastassopoulou C, Tsakris A, Bifulco GN, et al
    Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach.
    PLoS One. 2020;15:e0240649.
    PubMed         Abstract available

  200. COTO J, Restrepo A, Cejas I, Prentiss S, et al
    The impact of COVID-19 on allied health professions.
    PLoS One. 2020;15:e0241328.
    PubMed         Abstract available

  201. MEYER VMC, Siqueira MM, Costa PFBM, Caetano BC, et al
    Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis.
    PLoS One. 2020;15:e0240452.
    PubMed         Abstract available

  202. LIU J, Li H, Luo M, Liu J, et al
    Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.
    PLoS One. 2020;15:e0241659.
    PubMed         Abstract available

  203. CONTI C, Fontanesi L, Lanzara R, Rosa I, et al
    Fragile heroes. The psychological impact of the COVID-19 pandemic on health-care workers in Italy.
    PLoS One. 2020;15:e0242538.
    PubMed         Abstract available

  204. BENETTI E, Giliberti A, Emiliozzi A, Valentino F, et al
    Clinical and molecular characterization of COVID-19 hospitalized patients.
    PLoS One. 2020;15:e0242534.
    PubMed         Abstract available

  205. WEBB JB, Bray A, Asare PK, Clipp RB, et al
    Computational simulation to assess patient safety of uncompensated COVID-19 two-patient ventilator sharing using the Pulse Physiology Engine.
    PLoS One. 2020;15:e0242532.
    PubMed         Abstract available

  206. CHARLTON M, Stanley SA, Whitman Z, Wenn V, et al
    The effect of constitutive pigmentation on the measured emissivity of human skin.
    PLoS One. 2020;15:e0241843.
    PubMed         Abstract available

  207. GOODACRE S, Thomas B, Lee E, Sutton L, et al
    Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: Observational cohort study.
    PLoS One. 2020;15:e0240206.
    PubMed         Abstract available

  208. CHEN H, He J, Song W, Wang L, et al
    Modeling and interpreting the COVID-19 intervention strategy of China: A human mobility view.
    PLoS One. 2020;15:e0242761.
    PubMed         Abstract available

  209. SCHLESINGER T, Weissbrich B, Wedekink F, Notz Q, et al
    Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    PLoS One. 2020;15:e0242917.
    PubMed         Abstract available

  210. THOMAIER L, Teoh D, Jewett P, Beckwith H, et al
    Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic.
    PLoS One. 2020;15:e0242767.
    PubMed         Abstract available

  211. JANG SB, Lee SH, Lee DE, Park SY, et al
    Deep-learning algorithms for the interpretation of chest radiographs to aid in the triage of COVID-19 patients: A multicenter retrospective study.
    PLoS One. 2020;15:e0242759.
    PubMed         Abstract available

  212. PETROVIC D, Petrovic M, Bojkovic N, Cokic VP, et al
    An integrated view on society readiness and initial reaction to COVID-19: A study across European countries.
    PLoS One. 2020;15:e0242838.
    PubMed         Abstract available

  213. BOUSSOUAR S, Wagner M, Donciu V, Pasi N, et al
    Diagnostic performance of chest computed tomography during the epidemic wave of COVID-19 varied as a function of time since the beginning of the confinement in France.
    PLoS One. 2020;15:e0242840.
    PubMed         Abstract available

  214. KING CS, Sahjwani D, Brown AW, Feroz S, et al
    Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure.
    PLoS One. 2020;15:e0242651.
    PubMed         Abstract available

  215. INDENBAUM V, Koren R, Katz-Likvornik S, Yitzchaki M, et al
    Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
    PLoS One. 2020;15:e0241164.
    PubMed         Abstract available

  216. FILARDO TD, Khan MR, Krawczyk N, Galitzer H, et al
    Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020).
    PLoS One. 2020;15:e0242760.
    PubMed         Abstract available

  217. YOUNIE S, Mitchell C, Bisson MJ, Crosby S, et al
    Improving young children's handwashing behaviour and understanding of germs: The impact of A Germ's Journey educational resources in schools and public spaces.
    PLoS One. 2020;15:e0242134.
    PubMed         Abstract available

  218. YU D, Ininbergs K, Hedman K, Giske CG, et al
    Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19.
    PLoS One. 2020;15:e0242533.
    PubMed         Abstract available

  219. LIU L, Miller HJ, Scheff J
    The impacts of COVID-19 pandemic on public transit demand in the United States.
    PLoS One. 2020;15:e0242476.
    PubMed         Abstract available

  220. BONNEVIE E, Rosenberg SD, Kummeth C, Goldbarg J, et al
    Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine.
    PLoS One. 2020;15:e0240828.
    PubMed         Abstract available

  221. CAULKINS J, Grass D, Feichtinger G, Hartl R, et al
    How long should the COVID-19 lockdown continue?
    PLoS One. 2020;15:e0243413.
    PubMed         Abstract available

  222. CUNNINGHAM GB, Wigfall LT
    Race, explicit racial attitudes, implicit racial attitudes, and COVID-19 cases and deaths: An analysis of counties in the United States.
    PLoS One. 2020;15:e0242044.
    PubMed         Abstract available

  223. BOUZID D, Mullaert J, Le Hingrat Q, Laurent O, et al
    Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.
    PLoS One. 2020;15:e0243261.
    PubMed         Abstract available

  224. SALLAM M, Dababseh D, Yaseen A, Al-Haidar A, et al
    COVID-19 misinformation: Mere harmless delusions or much more? A knowledge and attitude cross-sectional study among the general public residing in Jordan.
    PLoS One. 2020;15:e0243264.
    PubMed         Abstract available

  225. YLLI A, Wu YY, Burazeri G, Pirkle C, et al
    The lower COVID-19 related mortality and incidence rates in Eastern European countries are associated with delayed start of community circulation.
    PLoS One. 2020;15:e0243411.
    PubMed         Abstract available

  226. MORGENSTERN-KAPLAN D, Buitano-Tang B, Martinez-Gil M, Zaldivar-Perez Pavon A, et al
    U-shaped-aggressiveness of SARS-CoV-2: Period between initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study.
    PLoS One. 2020;15:e0243268.
    PubMed         Abstract available

  227. PUYAT JH, Ahmad H, Avina-Galindo AM, Kazanjian A, et al
    A rapid review of home-based activities that can promote mental wellness during the COVID-19 pandemic.
    PLoS One. 2020;15:e0243125.
    PubMed         Abstract available

  228. LANI-LOUZADA R, Ramos CDVF, Cordeiro RM, Sadun AA, et al
    Retinal changes in COVID-19 hospitalized cases.
    PLoS One. 2020;15:e0243346.
    PubMed         Abstract available

  229. SOCOLOVITHC RL, Fumis RRL, Tomazini BM, Pastore L, et al
    Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study.
    PLoS One. 2020;15:e0243269.
    PubMed         Abstract available

  230. KONISHI T
    Principal component analysis of coronaviruses reveals their diversity and seasonal and pandemic potential.
    PLoS One. 2020;15:e0242954.
    PubMed         Abstract available

  231. D'EMDEN M, McLeod D, Ungerer J, Appleton C, et al
    Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment.
    PLoS One. 2020;15:e0243192.
    PubMed         Abstract available

  232. FERNANDEZ-FONTELO A, Morina D, Cabana A, Arratia A, et al
    Estimating the real burden of disease under a pandemic situation: The SARS-CoV2 case.
    PLoS One. 2020;15:e0242956.
    PubMed         Abstract available

  233. TOCTO-ERAZO MR, Espindola-Zepeda JA, Montoya-Laos JA, Acuna-Zegarra MA, et al
    Lockdown, relaxation, and acme period in COVID-19: A study of disease dynamics in Hermosillo, Sonora, Mexico.
    PLoS One. 2020;15:e0242957.
    PubMed         Abstract available

  234. K C M, Oral E, Straif-Bourgeois S, Rung AL, et al
    The effect of area deprivation on COVID-19 risk in Louisiana.
    PLoS One. 2020;15:e0243028.
    PubMed         Abstract available

  235. PSICHOGIOU M, Karabinis A, Pavlopoulou ID, Basoulis D, et al
    Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19.
    PLoS One. 2020;15:e0243025.
    PubMed         Abstract available

  236. OHSAWA Y, Tsubokura M
    Stay with your community: Bridges between clusters trigger expansion of COVID-19.
    PLoS One. 2020;15:e0242766.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  237. WONG F, Collins JJ
    Evidence that coronavirus superspreading is fat-tailed.
    Proc Natl Acad Sci U S A. 2020;117:29416-29418.
    PubMed         Abstract available

  238. MIORIN L, Kehrer T, Sanchez-Aparicio MT, Zhang K, et al
    SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Proc Natl Acad Sci U S A. 2020;117:28344-28354.
    PubMed         Abstract available

  239. SEITZ BM, Aktipis A, Buss DM, Alcock J, et al
    The pandemic exposes human nature: 10 evolutionary insights.
    Proc Natl Acad Sci U S A. 2020;117:27767-27776.
    PubMed         Abstract available

  240. LUMENG JC, Chavous TM, Lok AS, Sen S, et al
    Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:27749-27753.

  241. KORTESSIS N, Simon MW, Barfield M, Glass GE, et al
    The interplay of movement and spatiotemporal variation in transmission degrades pandemic control.
    Proc Natl Acad Sci U S A. 2020;117:30104-30106.
    PubMed         Abstract available

  242. POLYAKOVA M, Kocks G, Udalova V, Finkelstein A, et al
    Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts.
    Proc Natl Acad Sci U S A. 2020;117:27934-27939.
    PubMed         Abstract available

  243. STOKES GL, Lynch AJ, Lowe BS, Funge-Smith S, et al
    COVID-19 pandemic impacts on global inland fisheries.
    Proc Natl Acad Sci U S A. 2020;117:29419-29421.
    PubMed         Abstract available

  244. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed         Abstract available

  245. RELMAN DA
    Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:29246-29248.

  246. BAKER RE, Park SW, Yang W, Vecchi GA, et al
    The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Proc Natl Acad Sci U S A. 2020;117:30547-30553.
    PubMed         Abstract available

  247. CASADEVALL A, Pirofski LA
    In fatal COVID-19, the immune response can control the virus but kill the patient.
    Proc Natl Acad Sci U S A. 2020;117:30009-30011.

  248. NISHI A, Dewey G, Endo A, Neman S, et al
    Network interventions for managing the COVID-19 pandemic and sustaining economy.
    Proc Natl Acad Sci U S A. 2020;117:30285-30294.
    PubMed         Abstract available

  249. XU X, Han M, Li T, Sun W, et al
    Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
    Proc Natl Acad Sci U S A. 2020;117:30027-30028.

  250. YANG C, Liu E, Liu M
    Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:30025-30026.

  251. WANG Y, Mao Q, Zhou X
    Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
    Proc Natl Acad Sci U S A. 2020;117:30896-30897.

  252. SRIRAM K, Loomba R, Insel PA
    Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Proc Natl Acad Sci U S A. 2020;117:29274-29282.
    PubMed         Abstract available

  253. WU M, Chen Y, Xia H, Wang C, et al
    Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:28336-28343.
    PubMed         Abstract available

  254. KAMPF G
    Protective effect of mandatory face masks in the public-relevant variables with likely impact on outcome were not considered.
    Proc Natl Acad Sci U S A. 2020;117:27076-27077.

  255. NG QX, De Deyn MLZQ, Yeo WS
    Do face masks help? is not the question.
    Proc Natl Acad Sci U S A. 2020;117:27078-27079.

  256. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.


  257. SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
    Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
    PubMed         Abstract available

  258. DEGELING C, Williams J, Carter SM, Moss R, et al
    Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
    PubMed         Abstract available

  259. SARASTY O, Carpio CE, Hudson D, Guerrero-Ochoa PA, et al
    The demand for a COVID-19 vaccine in Ecuador.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31439.
    PubMed         Abstract available

  260. BOTHUN LS
    COVID-19: The worst date to the senior dance.
    Vaccine. 2020;38:8066-8067.

  261. GUEBRE-XABIER M, Patel N, Tian JH, Zhou B, et al
    NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
    Vaccine. 2020 Oct 23. pii: S0264-410X(20)31373.
    PubMed         Abstract available

  262. BELL S, Clarke R, Mounier-Jack S, Walker JL, et al
    Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
    Vaccine. 2020 Oct 19. pii: S0264-410X(20)31321.
    PubMed         Abstract available


  263. SEYED HOSSEINI E, Riahi Kashani N, Nikzad H, Azadbakht J, et al
    The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
    Virology. 2020;551:1-9.
    PubMed         Abstract available

  264. LI L, Liang Y, Hu F, Yan H, et al
    Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Virology. 2020;551:26-35.
    PubMed         Abstract available

    Virus Res

  265. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".
    Virus Res. 2020;290:198173.
    PubMed         Abstract available

  266. KHARE P, Sahu U, Pandey SC, Samant M, et al
    Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Virus Res. 2020;290:198169.
    PubMed         Abstract available

  267. KILLICK R, Ballard C, Doherty P, Williams G, et al
    Transcription-based drug repurposing for COVID-19.
    Virus Res. 2020;290:198176.
    PubMed         Abstract available

  268. CABBAB ILN, Manalo RVM
    Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Virus Res. 2021;291:198190.
    PubMed         Abstract available

  269. RAJEEV R, Prathiviraj R, Kiran GS, Selvin J, et al
    Zoonotic evolution and implications of microbiome in viral transmission and infection.
    Virus Res. 2020;290:198175.
    PubMed         Abstract available

  270. TAHAGHOGHI-HAJGHORBANI S, Zafari P, Masoumi E, Rajabinejad M, et al
    The role of dysregulated immune responses in COVID-19 pathogenesis.
    Virus Res. 2020;290:198197.
    PubMed         Abstract available

  271. PIERETTI JC, Rubilar O, Weller RB, Tortella GR, et al
    Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Virus Res. 2021;291:198202.
    PubMed         Abstract available

  272. CATTEL F, Giordano S, Bertiond C, Lupia T, et al
    Ozone therapy in COVID-19: A narrative review.
    Virus Res. 2021;291:198207.
    PubMed         Abstract available

  273. YAMASAKI Y, Ooka S, Tsuchida T, Nakamura Y, et al
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
    Virus Res. 2020;290:198089.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.